Not an approved drug
BPC-157 has not been approved by the FDA for any use. It is not an approved medication in the United States.
That is why nearly every vendor selling it labels it "research use only" or "not for human consumption" — marketing an unapproved compound for human use is what draws regulatory attention.
Compounding status has changed
Whether compounding pharmacies may prepare a substance depends on regulatory categorization, and BPC-157's standing in that framework has shifted in recent years following FDA review of certain bulk substances.
Because this area moves, current status should be confirmed with a licensed provider or pharmacist rather than taken from any article — including this one.
What it means practically
Buying research-use compounds is not typically where enforcement lands; regulators focus on sellers marketing unapproved compounds for human use or making treatment claims.
The practical risks fall on the buyer: no clinical evaluation of suitability, no guaranteed purity, and no recourse if the product is not what the label says.
Also worth knowing
BPC-157 is prohibited in sport under the World Anti-Doping Agency's list. Anyone subject to testing should treat that as decisive.
If a vendor tells you BPC-157 is FDA-approved, that is false, and it tells you what the rest of their claims are worth.